WARRIOR Trial: Outcomes to Reduce Events in Non-Obstructive Coronary Artery Disease cover art

WARRIOR Trial: Outcomes to Reduce Events in Non-Obstructive Coronary Artery Disease

WARRIOR Trial: Outcomes to Reduce Events in Non-Obstructive Coronary Artery Disease

Listen for free

View show details

About this listen

Funded by the Congressionally Directed Medical Research Programs (CDMRP) of the Department of Defense, the WARRIOR (Women's IschemiA TRial to Reduce events In non-ObstRuctive CAD) Trial addresses the urgent need for evidence-based care in a growing population of patients—particularly women—experiencing ischemia without obstructive coronary artery disease (INOCA).

This clinical strategy trial compares optimal medical therapy with usual care in women with angina but no significant coronary blockages. In this episode, Drs. Nanette Kass Wenger and Noel Bairey Merz discuss the trial’s design, enrollment progress, follow-up strategies, and the primary and secondary outcomes that could reshape cardiovascular care for women.

Subscribe on Apple Podcasts || Subscribe to ACCEL

activate_mytile_page_redirect_t1

What listeners say about WARRIOR Trial: Outcomes to Reduce Events in Non-Obstructive Coronary Artery Disease

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.